Evolution of normal and neoplastic tissue stem cells: Progress after Robert Hooke

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 370, Issue 1680, 2015, Pages

  Weissman, Irving ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Cancer; Competition; Leukaemia; Neoplasm; Stem cell

Indexed keywords

ANTIBODY; CANCER; CELLS AND CELL COMPONENTS; COMPETITIVE ABILITY; GENE EXPRESSION; METAZOAN; MUTATION;

UNITED KINGDOM; UNITED STATES;

METAZOA;

CD47 ANTIGEN;

ANIMAL; CANCER STEM CELL; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; EVOLUTION; HUMAN; METASTASIS; MUTATION; PATHOLOGY; PHYSIOLOGY; STEM CELL;

ANIMALS; ANTIGENS, CD47; BIOLOGICAL EVOLUTION; CELL DIFFERENTIATION; CELL MOVEMENT; HUMANS; MUTATION; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; STEM CELLS;

EID: 84942932615     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2014.0364     Document Type: Review

References (117)

1. Weissman IL. 2000 Stem cells: units of development, units of regeneration, and units in evolution. Cell 100, 157–168. (doi:10.1016/S0092-8674(00)81692-X)
2. Loh KM, Lim B, Ang LT. 2015 Ex uno plures: molecular designs for embryonic pluripotency. Physiol. Rev. 95, 245–295. (doi:10.1152/physrev.00001.2014)
3. Kucia M, Wysoczynski M, Ratajczak J, Ratajczak MZ. 2008 Identification of very small embryonic like (VSEL) stem cells in bone marrow. Cell Tissue Res. 331, 125–134. (doi:10.1007/s00441-007-0485-4)
4. Beltrami AP et al. 2007 Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 110, 3438–3446. (doi:10.1182/blood-2006-11-055566)
5. Blau HM, Brazelton TR, Weimann JM. 2001 The evolving concept of a stem cell: entity or function? Cell 105, 829–841. (doi:10.1016/S0092-8674(01)00409-3)
6. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. 1999 Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283, 534–537. (doi:10.1126/science.283.5401.534)
7. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ. 2001 Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105, 369–377. (doi:10.1016/S0092-8674(01)00328-2)
8. Jiang Y et al. 2002 Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41–49. (doi:10.1038/nature00870)
9. Orlic D et al. 2001 Bone marrow cells regenerate infarcted myocardium. Nature 410, 701–705. (doi:10.1038/35070587)
10. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. 2000 Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290, 1779–1782. (doi:10.1126/science.290.5497.1779)
11. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. 2002 Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297, 2256–2259. (doi:10.1126/science.1074807)
12. Miyanishi M, Mori Y, Seita J, Chen JY, Karten S, Chan CKF, Nakauchi H, Weissman IL. 2013 Do pluripotent stem cells exist in adult mice as very small embryonic stem cells? Stem Cell Rep. 1, 198–208. (doi:10.1016/j.stemcr.2013.07.001)
13. Buss LW. 1982 Somatic cell parasitism and the evolution of somatic tissue compatibility. Proc. Natl Acad. Sci. USA 79, 5337–5341. (doi:10.1073/pnas.79.17.5337)
14. Milkman R. 1967 Genetic and developmental studies on Botryllus schlosseri. Biol. Bull. 132, 229–243. (doi:10.2307/1539891)
15. Laird DJ, Weissman IL. 2004 Telomerase maintained in self-renewing tissues during serial regeneration of the urochordate Botryllus schlosseri. Dev. Biol. 273, 185–194. (doi:10.1016/j.ydbio.2004.05.029)
16. Oka H, Watanabe H. 1957 Vascular budding, a new type of budding in Botryllus. Biol. Bull. 112, 225–240. (doi:10.2307/1539200)
17. Schlumpberger JM, Weissman IL, Scofield VL. 1984 Monoclonal antibodies developed against Botryllus blood cell antigens bind to cells of distinct lineages during embryonic development. J. Exp. Zool. 229, 205–213. (doi:10.1002/jez.1402290205)
18. Schlumpberger JM, Weissman IL, Scofield VL. 1984 Separation and labeling of specific subpopulations of Botryllus blood cells. J. Exp. Zool. 229, 401–411. (doi:10.1002/jez.1402290308)
19. Lauzon RJ, Ishizuka KJ, Weissman IL. 2002 Cyclical generation and degeneration of organs in a colonial urochordate involves crosstalk between old and new: a model for development and regeneration. Dev. Biol. 249, 333–348. (doi:10.1006/dbio.2002.0772)
20. Laird DJ, De Tomaso AW, Weissman IL. 2005 Stem cells are units of natural selection in a colonial ascidian. Cell 123, 1351–1360. (doi:10.1016/j.cell.2005.10.026)
21. Steinbeck J. 1955 The Log from the Sea of Cortez 136–137. New York, NY: Penguin Books.
22. Stoner DS, Rinkevich B, Weissman IL. 1999 Heritable germ and somatic cell lineage competitions in chimeric colonial protochordates. Proc. Natl Acad. Sci. USA 96, 9148–9153. (doi:10.1073/pnas.96.16.9148)
23. Sabbadin A. 1962 Le basi genetiche dell capacita di fusione fra colonie in Botryllus schlosseri (Ascidiacea). Atti. Accad. Na Lincei. Rend. 32, 1031–1035.
24. Scofield VL, Schlumpberger JM, West LA, Weissman IL. 1982 Protochordate allorecognition is controlled by a MHC-like gene system. Nature 295, 499–502. (doi:10.1038/295499a0)
25. Oka H, Watanabe H. 1960 Problems of colony specificity in compound ascidians. Bull. Biol. Stn. Asamushi 10, 153–155.
26. Voskoboynik A et al. 2013 Identification of a colonial chordate histocompatibility gene. Science 341, 384–387. (doi:10.1126/science.1238036)
27. Stoner DS, Weissman IL. 1996 Somatic and germ cell parasitism in a colonial ascidian: possible role for a highly polymorphic allorecognition system. Proc. Natl Acad. Sci. USA 93, 15254–15259. (doi:10.1073/pnas.93.26.15254)
28. Ueno H, Turnbull BB, Weissman IL. 2009 Two-step oligoclonal development of male germ cells. Proc. Natl Acad. Sci. USA 106, 175–180. (doi:10.1073/pnas.0810325105)
29. Rossi DJ, Jamieson CH, Weissman IL. 2008 Stems cells and the pathways to aging and cancer. Cell 132, 681–696. (doi:10.1016/j.cell.2008.01.036)
30. Beerman I, Bhattacharya D, Zandi S, Sigvardsson M, Weissman IL, Bryder D, Rossi DJ. 2010 Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc. Natl Acad. Sci. USA 107, 5465–5470. (doi:10.1073/pnas.1000834107)
31. Chiquoine AD. 1954 The identification, origin, and migration of the primordial germ cells in the mouse embryo. Anat. Rec. 118, 135–146. (doi:10.1002/ar.1091180202)
32. Spangrude GJ, Heimfeld S, Weissman IL. 1988 Purification and characterization of mouse hematopoietic stem cells. Science 241, 58–62. (doi:10.1126/science.2898810)
33. Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ, Weissman IL. 2005 Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl Acad. Sci. USA 102, 9194–9199. (doi:10.1073/pnas.0503280102)
34. Morrison SJ, Prowse KR, Ho P, Weissman IL. 1996 Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5, 207–216. (doi:10.1016/S1074-7613(00)80316-7)
35. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. 1996 The aging of hematopoietic stem cells. Nat. Med. 2, 1011–1016. (doi:10.1038/nm0996-1011)
36. Weissman IL. 2015 Hematopoietic stem cells, regenerative medicine, and leukemogenesis. In Thomas’ hematopoietic cell transplantation: stem cell transplantation (eds SJ Forman, F Appelbaum, R Negrin, J Antin), 5th edn. Oxford, UK: Wiley- Blackwell.
37. Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ, Schrier SL, Weissman IL. 2011 Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc. Natl Acad. Sci. USA 108, 20012–20017. (doi:10.1073/pnas.1116110108)
38. Dykstra B, Kent D, Bowie M, McCaffrey L, Hamilton M, Lyons K, Lee SJ, Brinkman R, Eaves C. 2007 Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 1, 218–229. (doi:10.1016/j.stem.2007.05.015)
39. Kim M, Moon HB, Spangrude GJ. 2003 Major agerelated changes of mouse hematopoietic stem/progenitor cells. Ann. NY Acad. Sci. 996, 195–208. (doi:10.1111/j.1749-6632.2003.tb03247.x)
40. Sudo K, Ema H, Morita Y, Nakauchi H. 2000 Ageassociated characteristics of murine hematopoietic stem cells. J. Exp. Med. 192, 1273–1280. (doi:10.1084/jem.192.9.1273)
41. Cho RH, Sieburg HB, Muller-Sieburg CE. 2008 A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111, 5553–5561. (doi:10.1182/blood-2007-11-123547)
42. Morrison SJ, Weissman IL. 1994 The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1, 661–673. (doi:10.1016/1074-7613(94)90037-X)
43. Akashi K, Traver D, Miyamoto T, Weissman IL. 2000 A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193–197. (doi:10.1038/35004599)
44. Manz MG, Miyamoto T, Akashi K, Weissman IL. 2002 Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl Acad. Sci. USA 99, 11872–11877. (doi:10.1073/pnas.172384399)
45. Kondo M, Weissman IL, Akashi K. 1997 Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661–672. (doi:10.1016/S0092-8674(00)80453-5)
46. Na Nakorn T, Traver D, Weissman IL, Akashi K. 2002 Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J. Clin. Invest. 109, 1579–1585. (doi:10.1172/JCI15272)
47. Traver D, Akashi K, Weissman IL, Lagasse E. 1998 Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 9, 47–57. (doi:10.1016/S1074-7613(00)80587-7)
48. Weissman I. 2005 Stem cell research: paths to cancer therapies and regenerative medicine. J. Am. Med. Assoc. 294, 1359–1366. (doi:10.1001/jama.294.11.1359)
49. Miyamoto T, Weissman IL, Akashi K. 2000 AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl Acad. Sci. USA 97, 7521–7526. (doi:10.1073/pnas.97.13.7521)
50. Majeti R et al. 2009 Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc. Natl Acad. Sci. USA 106, 3396–3401. (doi:10.1073/pnas.0900089106)
51. Jamieson CH et al. 2004 Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351, 657–667. (doi:10.1056/NEJMoa040258)
52. Fialkow PJ, Jacobson RJ, Papayannopoulou T. 1977 Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med. 63, 125–130. (doi:10.1016/0002-9343(77)90124-3)
53. Nowell PC, Hungerford DA. 1960 A minute chromosome in human chronic granulocytic leukemia. Science 132, 1947. (doi:10.1126/science.132.3444.1947)
54. Rowley JD. 1973 Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290–293. (doi:10.1038/243290a0)
55. Pang WW, Pluvinage JV, Price EA, Sridhar K, Arber DA, Greenberg PL, Schrier SL, Park CY, Weissman IL. 2013 Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc. Natl Acad. Sci. USA 110, 3011–3016. (doi:10.1073/pnas.1222861110)
56. Abrahamsson AE et al. 2009 Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Proc. Natl Acad. Sci. USA 106, 3925–3929. (doi:10.1073/pnas.0900189106)
57. Jamieson CH et al. 2006 The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc. Natl Acad. Sci. USA 103, 6224–6229. (doi:10.1073/pnas.0601462103)
58. Nangalia J et al. 2013 Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N. Engl. J. Med. 369, 2391–2405. (doi:10.1056/NEJMoa1312542)
59. Jan M, Snyder TM, Corces-Zimmerman MR, Vyas P, Weissman IL, Quake SR, Majeti R. 2012 Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci. Transl. Med. 4, 149ra118. (doi:10.1126/scitranslmed.3004315)
60. Corces-Zimmerman MR, Hong WJ, Weissman IL, Medeiros BC, Majeti R. 2014 Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc. Natl Acad. Sci. USA 111, 2548–2553. (doi:10.1073/pnas.1324297111)
61. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL. 2000 Direct isolation of human central nervous system stem cells. Proc. Natl Acad. Sci. USA 97, 14720–14725. (doi:10.1073/pnas.97.26.14720)
62. Cheshier SH, Kalani MY, Lim M, Ailles L, Huhn SL, Weissman IL. 2009 A neurosurgeon’s guide to stem cells, cancer stem cells, and brain tumor stem cells. Neurosurgery 65, 237–249; discussion 249–250; quiz N236. (doi:10.1227/01.NEU.0000349921.14519.2A)
63. Barker N et al. 2007 Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003–1007. (doi:10.1038/nature06196)
64. Merlos-Suarez A et al. 2011 The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8, 511–524. (doi:10.1016/j.stem.2011.02.020)
65. Weissman IL. 1971 Tumor immunology. Calif. Med. 114, 76–78.
66. Weissman IL. 1973 Tumor immunity in vivo: evidence that immune destruction of tumor leaves ‘bystander’ cells intact. J. Natl Cancer Inst. 51, 443–448.
67. Gallatin M, Weissman IL, Butcher E. 1983 Lymphocyte recirculation: a molecular basis for the recognition of vascular endothelium. In Intercellular Communication in Leukocyte Function. Proc. of the 15th Leukocyte Culture Conf., Pacific Grove, CA, USA (eds JW Parker, RL O’Brien) 645–648. Indianapolis, IN: John Wiley and Sons.
68. Spangrude GJ, Weissman IL. 1988 Mature T cells generated from single thymic clones are phenotypically and functionally heterogeneous. J. Immunol. 141, 1877–1890.
69. Bargatze RF, Wu NW, Weissman IL, Butcher EC. 1987 High endothelial venule binding as a predictor of the dissemination of passaged murine lymphomas. J. Exp. Med. 166, 1125–1131. (doi:10.1084/jem.166.4.1125)
70. Sher BT, Bargatze R, Holzmann B, Gallatin WM, Matthews D, Wu N, Picker L, Butcher EC, Weissman IL. 1988 Homing receptors and metastasis. Adv. Cancer Res. 51, 361–390. (doi:10.1016/S0065-230X(08)60226-2)
71. Qian F, Vaux DL, Weissman IL. 1994 Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 77, 335–347. (doi:10.1016/0092-8674(94)90149-X)
72. Brocke S, Piercy C, Steinman L, Weissman IL, Veromaa T. 1999 Antibodies to CD44 and integrin a4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl Acad. Sci. USA 96, 6896–6901. (doi:10.1073/pnas.96.12.6896)
73. Yang XD, Michie SA, Mebius RE, Tisch R, Weissman I, McDevitt HO. 1996 The role of cell adhesion molecules in the development of IDDM: implications for pathogenesis and therapy. Diabetes 45, 705–710. (doi:10.2337/diab.45.6.705)
74. Wagers AJ, Allsopp RC, Weissman IL. 2002 Changes in integrin expression are associated with altered homing properties of Lin2/loThy1.1loSca-1þc-kitþ hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp. Hematol. 30, 176–185. (doi:10.1016/S0301-472X(01)00777-9)
75. Kina T, Majumdar AS, Heimfeld S, Kaneshima H, Holzmann B, Katsura Y, Weissman IL. 1991 Identification of a 107-kD glycoprotein that mediates adhesion between stromal cells and hematolymphoid cells. J. Exp. Med. 173, 373–381. (doi:10.1084/jem.173.2.373)
76. Miyake K, Weissman IL, Greenberger JS, Kincade PW. 1991 Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J. Exp. Med. 173, 599–607. (doi:10.1084/jem.173.3.599)
77. Weissman I, Papaioannou V, Gardner R. 1978 Fetal hematopoietic origins of the adult hematolymphoid system. In Cold Spring Harbor Conf. on Cell Proliferation, vol. 5. Differentiation of normal and neoplastic hematopoietic cells. Books A and B. Meeting, Cold Spring Harbor, NY, USA, 29 August–3 September, 1977 (eds BPAM Clarkson, ET James) (Book A), Xiþ463p. (Book B). Illus, 33–47. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
78. Hoeffel G et al. 2012 Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J. Exp. Med. 209, 1167–1181. (doi:10.1084/jem.20120340)
79. Ikuta K, Kina T, MacNeil I, Uchida N, Peault B, Chien YH, Weissman IL. 1990 A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell 62, 863–874. (doi:10.1016/0092-8674(90)90262-D)
80. Mebius RE, Streeter PR, Michie S, Butcher EC, Weissman IL. 1996 A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4þ CD3- cells to colonize lymph nodes. Proc. Natl Acad. Sci. USA 93, 11019–11024. (doi:10.1073/pnas.93.20.11019)
81. Mebius RE, Rennert P, Weissman IL. 1997 Developing lymph nodes collect CD4þCD32 LTbetaþ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493–504. (doi:10.1016/S1074-7613(00)80371-4)
82. Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I, Weissman IL, Cyster JG, Engleman EG. 2002 Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3, 1135–1141. (doi:10.1038/ni852)
83. Lagasse E, Weissman IL. 1997 Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89, 1021–1031. (doi:10.1016/S0092-8674(00)80290-1)
84. Chao MP, Majeti R, Weissman IL. 2011 Programmed cell removal: a new obstacle in the road to developing cancer. Nat. Rev. Cancer 12, 58–67. (doi:10.1038/nrc3171)
85. Lagasse E, Weissman IL. 1994 bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179, 1047–1052. (doi:10.1084/jem.179.3.1047)
86. Research PoIBoUI et al. 1999 International benchmarking of US immunology research, 450A. Washington, DC: The National Academies Press.
87. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. 2000 Role of CD47 as a marker of self on red blood cells. Science 288, 2051–2054. (doi:10.1126/science.288.5473.2051)
88. Morrison SJ, Wright DE, Weissman IL. 1997 Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc. Natl Acad. Sci. USA 94, 1908–1913. (doi:10.1073/pnas.94.5.1908)
89. Wright DE, Cheshier SH, Wagers AJ, Randall TD, Christensen JL, Weissman IL. 2001 Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood 97, 2278–2285. (doi:10.1182/blood.V97.8.2278)
90. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. 2001 Physiological migration of hematopoietic stem and progenitor cells. Science 294, 1933–1936. (doi:10.1126/science.1064081)
91. Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. 2009 CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138, 271–285. (doi:10.1016/j.cell.2009.05.046)
92. Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KDJr, van Rooijen N, Weissman IL. 2009 CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138, 286–299. (doi:10.1016/j.cell.2009.05.045)
93. Chan KS et al. 2009 Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl Acad. Sci. USA 106, 14016–14021. (doi:10.1073/pnas.0906549106)
94. Boiko AD et al. 2010 Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466, 133–137. (doi:10.1038/nature09161)
95. Chao MP, Alizadeh AA, Tang C, Jan M, Weissman- Tsukamoto R, Zhao F, Park CY, Weissman IL, Majeti R. 2011 Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res. 71, 1374–1384. (doi:10.1158/0008-5472.CAN-10-2238)
96. Willingham SB et al. 2012 The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc. Natl Acad. Sci. USA 109, 6662–6667. (doi:10.1073/pnas.1121623109)
97. Edris B et al. 2012 Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Proc. Natl Acad. Sci. USA 109, 6656–6661. (doi:10.1073/pnas.1121629109)
98. Chao MP et al. 2010 Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142, 699–713. (doi:10.1016/j.cell.2010.07.044)
99. Weiskopf K et al. 2013 Engineered SIRPalpha variants as immunotherapeutic adjuvants to anticancer antibodies. Science 341, 88–91. (doi:10.1126/science.1238856)
100. Chao MP, Tang C, Pachynski RK, Chin R, Majeti R, Weissman IL. 2011 Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy. Blood 118, 4890–4901. (doi:10.1182/blood-2011-02-338020)
101. Liu J et al. 2015 Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential. PLoS ONE.
102. Chao MP et al. 2010 Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci. Transl. Med. 2, p63ra94. (doi:10.1126/scitranslmed.3001375)
103. Feng M et al. 2015 Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk. Proc. Natl Acad. Sci. USA 112, 2145–2150. (doi:10.1073/pnas.1424907112)
104. Kepp O et al. 2014 Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology 3, e955691. (doi:10.4161/21624011.2014.955691)
105. Gardai SJ et al. 2005 Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321–334. (doi:10.1016/j.cell.2005.08.032)
106. Byrne JC, Ni Gabhann J, Stacey KB, Coffey BM, McCarthy E, Thomas W, Jefferies CA. 2013 Bruton’s tyrosine kinase is required for apoptotic cell uptake via regulating the phosphorylation and localization of calreticulin. J. Immunol. 190, 5207–5215. (doi:10.4049/jimmunol.1300057)
107. Lois C, Garcia-Verdugo JM, Alvarez-Buylla A. 1996 Chain migration of neuronal precursors. Science 271, 978–981. (doi:10.1126/science.271.5251.978)
108. Gage FH, Coates PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, Peterson DA, Suhr ST, Ray J. 1995 Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc. Natl Acad. Sci. USA 92, 11879–11883. (doi:10.1073/pnas.92.25.11879)
109. Reynolds BA, Weiss S. 1992 Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707–1710. (doi:10.1126/science.1553558)
110. Tamaki S et al. 2002 Engraftment of sorted/ expanded human central nervous system stem cells from fetal brain. J. Neurosci. Res. 69, 976–986. (doi:10.1002/jnr.10412)
111. Aimone JB, Wiles J, Gage FH. 2006 Potential role for adult neurogenesis in the encoding of time in new memories. Nat. Neurosci. 9, 723–727. (doi:10.1038/nn1707)
112. Garthe A, Behr J, Kempermann G. 2009 Adultgenerated hippocampal neurons allow the flexible use of spatially precise learning strategies. PLoS ONE 4, e5464. (doi:10.1371/journal.pone.0005464)
113. Cummings JL. 2004 Alzheimer’s disease. N. Engl. J. Med. 351, 56–67. (doi:10.1056/NEJMra040223)
114. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. 1996 Correlative memory deficits, Ab elevation, and amyloid plaques in transgenic mice. Science 274, 99–102. (doi:10.1126/science.274.5284.99)
115. Querfurth HW, LaFerla FM. 2010 Alzheimer’s disease. N. Engl. J. Med. 362, 329–344. (doi:10.1056/NEJMra0909142)
116. Hurowitz G, Weissman-Schindler E, Weissman IL. In preparation. A case report of successful recovery of a patient with voices in the brain treated with antiepileptics.
117. Duan X et al. 2007 Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 130, 1146–1158. (doi:10.1016/j.cell.2007.07.010)